Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli

Abstract Background Due to limited therapeutic options, the spread of extended-spectrum beta-lactamases (ESBLs) have become a major public health concern. We conducted a prospective, randomized, open-label comparison of the therapeutic efficacy of piperacillin-tazobactam (PTZ), cefepime, and ertapen...

Full description

Bibliographic Details
Main Authors: Yu Bin Seo, Jacob Lee, Young Keun Kim, Seung Soon Lee, Jeong-a Lee, Hyo Youl Kim, Young Uh, Han-Sung Kim, Wonkeun Song
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Infectious Diseases
Subjects:
Extended spectrum
Beta-lactamase
Piperacillin-tazobactam
Cefepime
Ertapenem
Online Access:http://link.springer.com/article/10.1186/s12879-017-2502-x

Internet

http://link.springer.com/article/10.1186/s12879-017-2502-x

Similar Items